ProfileGDS4177 / 211815_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 72% 72% 69% 67% 65% 68% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated109.9572
GSM603099KU-812 non-treated111.2572
GSM603098KCL-22 Imatinib-treated98.1369
GSM603097KCL-22 non-treated81.2367
GSM603102JURL-MK1 Imatinib-treated70.1265
GSM603101JURL-MK1 non-treated81.9768